CONTAINER PRE-FILLED WITH BOTULINUM TOXIN Russian patent published in 2019 - IPC A61K9/00 A61K38/48 A61K47/26 A61Q19/08 

Abstract RU 2694820 C2

FIELD: medicine.

SUBSTANCE: present invention relates to a pre-filled glass container, such as a pre-filled glass syringe containing an aqueous composition of botulinum toxin. Described is a pre-filled glass syringe containing an aqueous botulinum toxin composition, the syringe comprising (a) a syringe barrel made of glass having a proximal end, a distal end and a substantially cylindrical wall extending therebetween, forming a cylinder opening, wherein the syringe barrel has a distally projecting cannula with a liquid passage extending therethrough communicating with the cylinder opening, the substantially cylindrical wall having an inner surface optionally coated with a barrier layer, (b) a closure device having an exit fastening portion that tightly connects and closes the distal open end of the syringe, wherein the outlet fastening part is made from an elastomeric material with an optionally coated surface, and (c) a piston rod assembly that extends into the proximal end of the syringe cylinder and includes a piston seal in a fluid-free sliding joint with a cylindrical clearance of the cylinder, wherein the piston seal is made of an elastomeric material with a coating which is optionally applied on at least a portion of the sealant of the piston, contacting with an aqueous composition of botulinum toxin during storage and/or injection, in which the elastomeric material of the outlet fastener is selected from isoprene rubber (IS), butadiene rubber (BR), butyl rubber, halogenated butyl rubber, butadiene-styrene rubber and mixtures thereof, and the elastomeric material of the piston sealer is selected from isoprene rubber (IS), butadiene rubber (BR), butyl rubber, halogenated butyl rubber, butadiene-styrene rubber and mixtures thereof, and wherein toxin activity does not decrease by more than 25 % relative to the initial activity of the toxin after storing the pre-filled glass syringe for 12 months at 5 °C, or 12 months at 25 °C, or 6 months at 30 °C.

EFFECT: technical result is an aqueous composition of botulinum toxin in a pre-filled container is stable for a long period of time at temperature ranging from low to ambient temperature.

14 cl, 4 tbl, 3 dwg

Similar patents RU2694820C2

Title Year Author Number
CONTAINER PRE-FILLED WITH BOTULINUM TOXIN 2015
  • Fogt Markus
RU2722290C2
SYRINGE SYSTEM PRE-FILLED WITH BOTULINUS TOXIN 2017
  • Fogt Markus
RU2745739C2
HIGH INTRODUCTION RATE OF NEUROTOXIC COMPONENT OF BOTULINUM TOXIN 2007
  • Marks Mattias
  • Grafe Zuzanne
  • Benekke Rajner
  • Dressler Dirk
RU2453333C2
PROTEIN STABILISATION FORMULATION FREE FROM MAMMALIAN EXCIPIENTS 2010
  • Tehjlor Kharol'D
  • Burger Markus
  • Mander Gerd J.
RU2539388C2
CONCENTRATED METHOTREXATE SOLUTIONS 2007
  • Vill' Khajner
RU2403044C1
PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY, CONTAINING IMMUNOGLOBULINS 2015
  • Pedrussio Rentso
  • Shtiger Regula
RU2748841C2
METHOD AND DEVICES FOR LYOPHILISATION, RECONSTITUTION AND INTRODUCTION OF RECONSTITUTED REACTANT 2005
  • Pikkhard Ehval'D
RU2384349C2
PROCESS FOR PREPARING HIGHLY PURE NEUROTOXIC COMPONENT OF BOTULINUM TOXIN AND USES THEREOF 2014
  • Pfajl Mikhael
  • Vizenburg Andreas
RU2663136C2
PRE-FILLED PHARMACEUTICAL PACKAGE CONTAINING A LIQUID FORMULATION BASED ON A VEGF ANTAGONIST 2016
  • Brokmejer Karsten
  • Vajkart Khristofer
  • Bennett Murraj Shtefen
  • Zhiro Zhan-Per
  • Shtryungman Tomas
RU2734958C2
PRE-FILLED PLASTIC SYRINGE CONTAINING VEGF ANTAGONIST 2015
  • Fiedler Bernd
RU2702748C2

RU 2 694 820 C2

Authors

Fogt Markus

Dates

2019-07-17Published

2015-12-22Filed